Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0088 | 0.0737 | 0.5 |
Brugia malayi | hypothetical protein | 0.0088 | 0.0737 | 0.0737 |
Chlamydia trachomatis | protoporphyrinogen oxidase | 0.0088 | 0.0737 | 0.5 |
Schistosoma mansoni | amine oxidase | 0.0088 | 0.0737 | 0.0809 |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.0088 | 0.0737 | 0.5 |
Mycobacterium ulcerans | oxidoreductase | 0.0088 | 0.0737 | 0.5 |
Schistosoma mansoni | amine oxidase | 0.0088 | 0.0737 | 0.0809 |
Loa Loa (eye worm) | hypothetical protein | 0.0088 | 0.0737 | 0.0737 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0434 | 0.9111 | 1 |
Onchocerca volvulus | 0.0471 | 1 | 0.5 | |
Plasmodium vivax | hypothetical protein, conserved | 0.0088 | 0.0737 | 0.5 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.0088 | 0.0737 | 0.5 |
Schistosoma mansoni | Protoporphyrinogen oxidase chloroplast/mitochondrial precursor | 0.0088 | 0.0737 | 0.0809 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0088 | 0.0737 | 0.0809 |
Loa Loa (eye worm) | hypothetical protein | 0.0125 | 0.1626 | 0.1626 |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.0088 | 0.0737 | 0.5 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.0088 | 0.0737 | 0.5 |
Toxoplasma gondii | histone lysine-specific demethylase LSD1/BHC110/KDMA1A | 0.0088 | 0.0737 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0471 | 1 | 1 |
Leishmania major | UDP-galactopyranose mutase | 0.0088 | 0.0737 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0088 | 0.0737 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0434 | 0.9111 | 0.9111 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0088 | 0.0737 | 0.5 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0088 | 0.0737 | 0.5 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0088 | 0.0737 | 0.5 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0088 | 0.0737 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0088 | 0.0737 | 0.5 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.0088 | 0.0737 | 0.5 |
Toxoplasma gondii | histone lysine-specific demethylase | 0.0088 | 0.0737 | 0.5 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.0125 | 0.1626 | 0.1626 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0434 | 0.9111 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0088 | 0.0737 | 0.0737 |
Mycobacterium ulcerans | monoamine oxidase | 0.0088 | 0.0737 | 0.5 |
Echinococcus multilocularis | 0.0088 | 0.0737 | 0.0809 | |
Echinococcus multilocularis | protoporphyrinogen oxidase | 0.0088 | 0.0737 | 0.0809 |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.0434 | 0.9111 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0434 | 0.9111 | 0.9111 |
Mycobacterium ulcerans | protoporphyrinogen oxidase | 0.0088 | 0.0737 | 0.5 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0088 | 0.0737 | 0.5 |
Mycobacterium ulcerans | dehydrogenase | 0.0088 | 0.0737 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
ED50 (functional) | = 1 uM | Inhibit the replication of CCRF-CEM cell line in vitro. | ChEMBL. | 1995894 |
ED50 (functional) | = 10 uM | Effective dose to inhibit the replication of P388 cell line in vitro. | ChEMBL. | 1995894 |
ED50 (functional) | = 20 uM | Effective dose to inhibit the replication of L1210 cell line in vitro. | ChEMBL. | 1995894 |
ED50 (functional) | = 30 uM | Effective dose to inhibit the replication of S180 cell line in vitro. | ChEMBL. | 1995894 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.